osm (ATCC)
Structured Review

Osm, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 180 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/osm/product/ATCC
Average 94 stars, based on 180 article reviews
Images
1) Product Images from "Oncostatin M Drives Th2 Polarized Allergic Airway Inflammation Through Fibroblast Reprogramming and Endoplasmic Reticulum Stress"
Article Title: Oncostatin M Drives Th2 Polarized Allergic Airway Inflammation Through Fibroblast Reprogramming and Endoplasmic Reticulum Stress
Journal: International Journal of Nanomedicine
doi: 10.2147/IJN.S535265
Figure Legend Snippet: OSM promotes IL-4 production in airway fibroblasts. ( A-B ) IL-4 expression profiles in fibroblast lines following 48 hr OSM exposure. ( C ) OSMR knockdown efficiency in WI-38 cells. ( D-E ) IL-4 mRNA ( D ) and protein ( E ) levels after OSMR RNAi. ( F-G ) In vivo OSM administration (7 days): IL-4 mRNA in lung fibroblasts ( F ) and protein in lung homogenates (G). Data shown as mean ± SD with individual points. Statistical analysis: ANOVA with Tukey’s test; * p <0.05; ** p <0.01; *** p <0.001; **** p <0.0001. RE: Relative expression.
Techniques Used: Expressing, Knockdown, In Vivo
Figure Legend Snippet: Transcriptomic profiling of OSM-activated airway fibroblasts. Lung fibroblasts from OSM- or PBS-treated mice (n=6/group) underwent RNA sequencing. ( A ) Volcano plot of differentially expressed genes (DEGs). ( B-C ) Th2-associated biological processes ( B ) and enriched pathways (C, red boxes). ( D ) Violin plot of Il4 expression. ( E-H ) Protein levels of endoplasmic reticulum stress (ERS) markers and IL-4. ( I ) Correlation heatmap between fibroblast parameters and BALF components. Data presented as mean ± SD ( D and E ) with individual points. Statistics: Student’s t -test ( D and E ) and Pearson’s correlation (F). * p <0.05. ** p <0.01; *** p<0.001 . Raw data (A-D): BioProject PRJNA11112352; SRA SRP508146. Abbreviations: IL-4/IL-5/IL-13 (samples from OSM-treated mice); p-PERK/p-eIF2α (phosphorylated forms); n-ATF4 (nuclear translocated); GSK (PERK inhibitor GSK2606414, 0.4 nM).
Techniques Used: RNA Sequencing, Expressing
Figure Legend Snippet: Synergistic activation of IL-4 promoter by ATF4-Mef2d-GATA3 axis.A, the amount of phosphorylated PERK (pPERK) in lung fibroblasts. ( B and C ) Immunoprecipitation showing ATF4-Mef2d interaction in lung fibroblasts from OSM-treated mice. ( D ) Predicted ATF4-Mef2d complex structure. ( E ) Confocal microscopy (630×) of subcellular His-Mef2d localization (in green) in ATF4-transfected HEK293 cells (the nuclei were stained with propidium iodide in red). ( F–H ) Cytoplasm Mef2d (F), nuclear Mef2d ( G ) and GATA3 ( H ) levels. E235 (5 µM; MCE): An inhibitor of ATF4. ( I ) Luciferase reporter assay of IL-4 promoter activation (A: ATF4; ( M ) Mef2d; ( G ) GATA3; muA: ATF4 mutant). ( J–K ) IL-4 mRNA ( I ) and protein ( J ) levels. GSK: (GSK2606414; 0.4 nM; MCE): An inhibitor of PERK. Data shown as mean ± SD with individual points. Statistical analysis: ANOVA with Tukey’s test; * p <0.05; ** p <0.01; *** p <0.001; **** p <0.0001. OD: Optical density.
Techniques Used: Activation Assay, Immunoprecipitation, Confocal Microscopy, Transfection, Staining, Luciferase, Reporter Assay, Mutagenesis
